CN104059075A - 8, 9-单,双取代的咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 - Google Patents
8, 9-单,双取代的咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 Download PDFInfo
- Publication number
- CN104059075A CN104059075A CN201410278693.0A CN201410278693A CN104059075A CN 104059075 A CN104059075 A CN 104059075A CN 201410278693 A CN201410278693 A CN 201410278693A CN 104059075 A CN104059075 A CN 104059075A
- Authority
- CN
- China
- Prior art keywords
- compound
- grams
- reaction
- milliliters
- dimethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- -1 di-substituted imidazo[1, 2-c]quinazolin-3(2H)-one Chemical class 0.000 title abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 59
- 238000006243 chemical reaction Methods 0.000 claims abstract description 53
- 239000002904 solvent Substances 0.000 claims abstract description 46
- 150000001412 amines Chemical class 0.000 claims abstract description 26
- 238000000746 purification Methods 0.000 claims abstract description 10
- 229940125898 compound 5 Drugs 0.000 claims abstract description 8
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940125782 compound 2 Drugs 0.000 claims abstract description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 48
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 30
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- 150000002460 imidazoles Chemical class 0.000 claims description 19
- 239000011541 reaction mixture Substances 0.000 claims description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- 238000001953 recrystallisation Methods 0.000 claims description 17
- 229960000583 acetic acid Drugs 0.000 claims description 15
- 239000012362 glacial acetic acid Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 238000000926 separation method Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 claims description 9
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical class CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 claims description 9
- 239000012265 solid product Substances 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- 238000004440 column chromatography Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 6
- 238000011084 recovery Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 claims description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 3
- RAFKCLFWELPONH-UHFFFAOYSA-N acetonitrile;dichloromethane Chemical compound CC#N.ClCCl RAFKCLFWELPONH-UHFFFAOYSA-N 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 10
- 125000000623 heterocyclic group Chemical group 0.000 abstract description 8
- 238000001308 synthesis method Methods 0.000 abstract description 4
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000035484 reaction time Effects 0.000 abstract description 2
- 239000003054 catalyst Substances 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000975 dye Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- KXZSVYHFYHTNBI-UHFFFAOYSA-N 1h-quinoline-2-thione Chemical class C1=CC=CC2=NC(S)=CC=C21 KXZSVYHFYHTNBI-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- TWWNPUZQYVWXJY-UHFFFAOYSA-N 1h-quinazoline-4-thione Chemical compound C1=CC=C2C(S)=NC=NC2=C1 TWWNPUZQYVWXJY-UHFFFAOYSA-N 0.000 description 1
- GVRRXASZZAKBMN-UHFFFAOYSA-N 4-chloroquinazoline Chemical compound C1=CC=C2C(Cl)=NC=NC2=C1 GVRRXASZZAKBMN-UHFFFAOYSA-N 0.000 description 1
- 150000005653 4-chloroquinolines Chemical class 0.000 description 1
- COABNVNLVJLMAS-UHFFFAOYSA-N 4-methylsulfanylquinazoline Chemical compound C1=CC=C2C(SC)=NC=NC2=C1 COABNVNLVJLMAS-UHFFFAOYSA-N 0.000 description 1
- 150000007636 5,6-membered heterocyclic compounds Chemical class 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003987 organophosphate pesticide Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410278693.0A CN104059075B (zh) | 2014-06-21 | 2014-06-21 | 8,9-单,双取代的咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410278693.0A CN104059075B (zh) | 2014-06-21 | 2014-06-21 | 8,9-单,双取代的咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104059075A true CN104059075A (zh) | 2014-09-24 |
CN104059075B CN104059075B (zh) | 2015-10-21 |
Family
ID=51547035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410278693.0A Active CN104059075B (zh) | 2014-06-21 | 2014-06-21 | 8,9-单,双取代的咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104059075B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104327086A (zh) * | 2014-11-14 | 2015-02-04 | 山东省鲁南煤化工工程技术研究院 | 一种具有光学活性的2h-咪唑并[1,2-c]喹唑啉-3酮化合物及其制备方法 |
CN105130910A (zh) * | 2015-07-30 | 2015-12-09 | 遵义医学院 | 一种表皮生长因子受体酪氨酸激酶抑制剂pd153035及其类似物的一锅合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000053654A (ja) * | 1998-08-10 | 2000-02-22 | Sumitomo Pharmaceut Co Ltd | 新規なキナゾリン誘導体 |
-
2014
- 2014-06-21 CN CN201410278693.0A patent/CN104059075B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000053654A (ja) * | 1998-08-10 | 2000-02-22 | Sumitomo Pharmaceut Co Ltd | 新規なキナゾリン誘導体 |
Non-Patent Citations (2)
Title |
---|
ALY,A. A.: "Synthesis and antimicrobial activity of some annelated quinazoline derivatives", 《JOURNAL OF THE CHINESE CHEMICAL SOCIETY》 * |
EL-MELIGIE, S等: "2-(2-Arylvinyl)-7-substituted –quinazolin -4(3H)-ones: synthesis, reactions and antimicrobial activity", 《INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104327086A (zh) * | 2014-11-14 | 2015-02-04 | 山东省鲁南煤化工工程技术研究院 | 一种具有光学活性的2h-咪唑并[1,2-c]喹唑啉-3酮化合物及其制备方法 |
CN105130910A (zh) * | 2015-07-30 | 2015-12-09 | 遵义医学院 | 一种表皮生长因子受体酪氨酸激酶抑制剂pd153035及其类似物的一锅合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104059075B (zh) | 2015-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Highly efficient synthesis of α-amino amidines from ynamides by the Cu-catalyzed three-component coupling reactions | |
CN105801575A (zh) | 一种咪唑并[1,2-a]吡啶的合成方法 | |
CN106866528A (zh) | 一种制备4‑氨基喹啉衍生物的方法 | |
CN104059075B (zh) | 8,9-单,双取代的咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 | |
CN109734662A (zh) | 一种三氟甲基取代二氢异喹啉酮衍生物及其制备方法 | |
CN104356110B (zh) | 一种硫诱导3,6‑芳香杂环不对称取代‑1,2,4,5‑四嗪化合物及其合成方法 | |
CN104844549A (zh) | 一种7-溴吡喃衍生物的制备方法 | |
CN103965203B (zh) | 一类咪唑[1,2-c]-喹唑啉-3(2H)-酮稠杂环化合物及其制备方法 | |
CN107311960A (zh) | 1,2,3‑苯并噻二唑类化合物的合成方法 | |
CN103694182B (zh) | 一种喹喔啉类化合物的制备方法 | |
Huang et al. | Tandem addition-cyclization reaction catalyzed by ytterbium chloride: An efficient one-step synthesis of 2-amino-4 H-3, 1-benzothiazine | |
CN104030994A (zh) | 1,2,3—三唑类化合物的合成方法 | |
CN110078766A (zh) | 膦酰化苯并咪唑并异喹啉酮类化合物及其制备方法 | |
CN102432553B (zh) | 喹唑啉衍生物的制备方法及其中间体 | |
CN105272987A (zh) | 一种3-氰基-n-错位卟啉化合物的制备方法 | |
CN111763222B (zh) | 用于制备依度沙班游离碱的中间体及其制备方法和应用 | |
CN104045643A (zh) | 一种铜催化水相制备吡唑并[1,5-c]喹唑啉骨架化合物的方法 | |
CN104447391A (zh) | 一种亚甲基双酰胺衍生物及其制备方法 | |
CN109265409B (zh) | 一种2-取代的苯并噁唑和2-取代的苯并噻唑及其衍生物的合成方法 | |
CN109265403B (zh) | 一种苯并咪唑及其衍生物的合成方法 | |
CN106883229A (zh) | 一种3‑羟基咪唑并[1,2‑a]吡啶衍生物的制备方法 | |
CN102718694B (zh) | 3-氰基取代吲哚化合物及其合成方法 | |
CN106543040B (zh) | 一种医药中间体氨基甲酸酯化合物的合成方法 | |
CN104860880A (zh) | 一种合成8-(硝基甲基)喹啉类化合物的方法 | |
CN104761420A (zh) | 一种在水相中用甲基芳烃和胺合成酰胺的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Xuejing Inventor after: Wang Feng Inventor after: Han Ying Inventor before: Liu Xuejing Inventor before: Wang Feng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU XUEJING WANG FENG TO: LIU XUEJING WANG FENG HAN YING |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Xuejing Inventor after: Han Ying Inventor after: Cao Han Inventor after: Wang Feng Inventor before: Liu Xuejing Inventor before: Wang Feng Inventor before: Han Ying |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU XUEJING WANG FENG HAN YING TO: LIU XUEJING HAN YING CAO HAN WANG FENG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200918 Address after: 3 / F, building 2, No. 115, Yangpu Road, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou City, Jiangsu Province Patentee after: Best (Suzhou) Pharmaceutical Co., Ltd Address before: 277160 School of chemistry, chemical and material science, Zaozhuang University, 1 Bei'an Road, Shizhong District, Shandong, Zaozhuang Patentee before: ZAOZHUANG University Patentee before: ENGINEERING AND TECHNOLOGY INSTITUTE OF LUNAN COAL CHEMICAL ENGINEERING |
|
TR01 | Transfer of patent right |